TRANSDERMAL DRUG DELIVERY TECHNOLOGY
We are Norkos Technologies, a fully integrated Biopharmaceutical and Pharmaceutical Company.
TRANSDERMAL PATCHES
NORKOS TECHNOLOGIES
Norkos Technologies LLC is a global leader in Transdermal Drug Delivery Systems located in the US with unparalleled expertise to formulate and design transdermal patches for controlled release up to 7 days and avoid the first pass metabolism to improve the API bioavailability. The company has an extensive history leveraging over 20 year's experience in Research and Development of transdermal adhesives, API solubility, flux studies, excipients, enhancers, release liners and Backings to design the transdermal system.
Our R&D team carefully select materials for adhesion and irritation compliance for regulatory agencies.
Norkos Technologies offers a full range of R&D, Process Development and Manufacturing to produce transdermal patches to improve quality of life and compliance for patients.
Norkos Technologies use a number of own technologies to produce proprietary brand and generic transdermal drug delivery systems in the following therapeutic Categories:
- Pain Management
- Cardiovascular Disease
- Central Nervous System
- Smoking Cessation
